EIF2AK3 and cancer: To widely explore the relationship of PERK expression and prognosis, the PrognoScan, K-M plotter, and UALCAN databases were employed to analyze the change of OS, RFS, and DMFS in the PERK high- and low-expression groups divided by the median in pan-cancer.